Class IITerminatedD-0161-2016
Drug recall · November 4, 2015
Xanax (alprazolam) tablets recall
Why: Subpotent Drug
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Xanax (alprazolam) tablets, 0.25 mg, 100-count bottle, Rx only, Distributed by Pharmacia & Upjohn Co. Division of Pfizer Inc, NY, NY 10017, NDC 0009-0029-01
- Lots / codes
Lot # C111054; Exp. 02/16
- Quantity
- 21,120 HDPE bottles
- Company
- Pfizer Inc., New York, NY
- Distribution
- Nationwide
- Initiated
- September 24, 2015 · Voluntary: Firm initiated
- Classified
- October 29, 2015
- Reported
- November 4, 2015
- Ended
- May 8, 2017
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Xanax
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.